-+ 0.00%
-+ 0.00%
-+ 0.00%
Jinshi Ya Pharmaceutical (300434.SZ) sales increased ahead of time. Net profit due to mother is expected to increase by 32.35% to 63.41% year-on-year in the first three quarters
Share
Listen to the news

According to the Zhitong Finance App, Jinshi Yayao (300434.SZ) released a performance forecast for the first three quarters of 2026. The net profit attributable to shareholders of listed companies for the first three quarters is expected to be 128 million yuan to 158 million yuan, an increase of 32.35% to 63.41% over the previous year.

During the reporting period, the company's operating trend was stable, revenue increased steadily, and profit levels increased. On the one hand, the company actively expands the market and stabilizes its core business; on the other hand, it promotes refined operation, implements cost reduction and efficiency, and continuously improves management and production processes. By optimizing the allocation of the market and the investment of various resources to improve the efficiency of resource allocation, expenses for the current period were reduced compared to the same period last year. The slight increase in operating income, combined with cost improvements brought about by internal management optimization, jointly promoted the growth of business performance in the current period. During the reporting period, the estimated impact of non-recurring profit and loss on net profit was approximately $12.3537 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending